Summary
- Current Price
- As of today, RCUS price is $24.97, down -0.36% on
- Current Price All-Time High
- RCUS price is currently -49.14% below its historical high of $49.10 set on
- Market Cap
- RCUS current market cap is $3B, up +141.57% over the past 365 days
- Revenue
- RCUS current annual revenue is $247.00M, down -4.26% year-over-year
- Next Earnings
- The next earnings release for RCUS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Arcus Biosciences, Inc. |
| Ticker | NYSE: RCUS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arcusbio.com |
| Employees | 627 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $24.97 | |
| Price, 1D Change | -0.36% | |
| $3B | ||
| - | ||
| - | ||
| 1.84 | ||
| $247.00M | ||
| Revenue, 1Y Change | -4.26% | |
| -$3.29 | ||
| EPS, 1Y Change | -4.64% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.29 | ||
| EPS Estimate | -$3.53 | N/A |
| EPS Est. Change | -7.40% | N/A |
| $247.00M | ||
| Revenue Estimate | $77.89M | N/A |
| Revenue Est. Change | -68.47% | N/A |
| Current Price | $24.97 | |
| Price Target | $42.50 | - |
| Price Tgt. Change | +70.20% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.24 | -$3.14 | +3.07% | |
| -$3.50 | -$3.29 | +6.09% | |
| -$3.53 | N/A | -7.40% | |
| -$3.39 | N/A | -2.99% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $261.59M | $258.00M | -1.37% | |
| $237.60M | $247.00M | +3.96% | |
| $77.89M | N/A | -68.47% | |
| $50.98M | N/A | -79.36% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $24.97 | |
| $24.74 | ||
| $28.17 | ||
| $24.51 | ||
| $27.43 | ||
| -$0.97 | ||
| 1.84 | ||
| $1.34 | ||
| 38.18 | ||
| 44.48% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $247.00M | ||
| -$3.29 | ||
| $237.00M | ||
| 95.95% | ||
| -$386.00M | ||
| -156.28% | ||
| -$353.00M | ||
| -142.92% | ||
| -$376.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.31 | ||
| 4.36 | ||
| 4.36 | ||
| - | ||
| 0 | ||
| 0.65 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 27.18 | ||
| 6.85 | ||
| -5.43 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $631.00M | ||
| $981.00M | ||
| $1.56B | ||
| $1.01B | ||
| $933.00M | ||
| $231.00M | ||
| $198.00M | ||
| $13.00M | ||
| $42.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $600.00M | ||
| $623.00M | ||
| $10.00M | ||
| $0.00 | ||
| $10.00M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$482.00M | ||
| $66.00M | ||
| $488.00M | ||
| $2.00M | ||
| -$484.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | ||
| Truist Securities | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| LifeSci Capital | ||
| Morgan Stanley | → | |
| Goldman Sachs | → | |
| Wedbush | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RCUS
FAQ
- What is the ticker symbol for Arcus Biosciences, Inc.?
- The ticker symbol for Arcus Biosciences, Inc. is NYSE:RCUS
- Does Arcus Biosciences, Inc. pay dividends?
- No, Arcus Biosciences, Inc. does not pay dividends
- What sector is Arcus Biosciences, Inc. in?
- Arcus Biosciences, Inc. is in the Healthcare sector
- What industry is Arcus Biosciences, Inc. in?
- Arcus Biosciences, Inc. is in the Biotechnology industry
- What country is Arcus Biosciences, Inc. based in?
- Arcus Biosciences, Inc. is headquartered in United States
- When did Arcus Biosciences, Inc. go public?
- Arcus Biosciences, Inc. initial public offering (IPO) was on March 14, 2018
- Is Arcus Biosciences, Inc. in the S&P 500?
- No, Arcus Biosciences, Inc. is not included in the S&P 500 index
- Is Arcus Biosciences, Inc. in the NASDAQ 100?
- No, Arcus Biosciences, Inc. is not included in the NASDAQ 100 index
- Is Arcus Biosciences, Inc. in the Dow Jones?
- No, Arcus Biosciences, Inc. is not included in the Dow Jones index
- When was Arcus Biosciences, Inc. last earnings report?
- Arcus Biosciences, Inc.'s most recent earnings report was on August 5, 2026
- When does Arcus Biosciences, Inc. report earnings?
- The next expected earnings date for Arcus Biosciences, Inc. is October 27, 2026
Data Sources & References
- RCUS Official Website www.arcusbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1724521/000172452126000009/0001724521-26-000009-index.htm
- RCUS Profile on Yahoo Finance finance.yahoo.com/quote/RCUS
- RCUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rcus